Featured Research

from universities, journals, and other organizations

Preventive Removal Of Both Breasts Reduces Chance Of Breast Cancer In Women At Elevated Risk

Date:
March 24, 2005
Source:
Harvard University
Summary:
Women with a moderately elevated risk of breast cancer who underwent surgery to have both breasts removed reduced their risk of getting the disease by about 95 percent, a recent study concludes. The study, conducted by scientists at six health plans, is published in the March 14 issue of the Archives of Internal Medicine.

Women with a moderately elevated risk of breast cancer who underwent surgery to have both breasts removed reduced their risk of getting the disease by about 95 percent, a recent study concludes. The study, conducted by scientists at six health plans, is published in the March 14 issue of the Archives of Internal Medicine.

"Prophylactic mastectomy appears very effective in preventing breast cancer, but choosing this procedure is a complex decision," said Ann M. Geiger, lead author of the study. "Prophylactic mastectomy prevents breast cancer but also carries a risk of complications and may impact a woman's psychosocial health. We suggest a woman considering the procedure talk to her doctor, family, and friends, and get genetic counseling to help her understand her risk of breast cancer and learn about all her options. In addition to prophylactic mastectomy, women may choose to manage their risk with tamoxifen, prophylactic oophorectomy, regular mammograms, and possibly MRI."

The study's patients were female members of multiple health plans who were 18 to 80 years of age between Jan. 1, 1979, and Dec. 31, 1998, and who had at least one breast cancer risk factor. The most often noted factors were having a family history of breast cancer, a personal history of atypical hyperplasia (a potentially pre-cancerous condition), and one or more benign breast biopsies.


Story Source:

The above story is based on materials provided by Harvard University. Note: Materials may be edited for content and length.


Cite This Page:

Harvard University. "Preventive Removal Of Both Breasts Reduces Chance Of Breast Cancer In Women At Elevated Risk." ScienceDaily. ScienceDaily, 24 March 2005. <www.sciencedaily.com/releases/2005/03/050323134132.htm>.
Harvard University. (2005, March 24). Preventive Removal Of Both Breasts Reduces Chance Of Breast Cancer In Women At Elevated Risk. ScienceDaily. Retrieved October 1, 2014 from www.sciencedaily.com/releases/2005/03/050323134132.htm
Harvard University. "Preventive Removal Of Both Breasts Reduces Chance Of Breast Cancer In Women At Elevated Risk." ScienceDaily. www.sciencedaily.com/releases/2005/03/050323134132.htm (accessed October 1, 2014).

Share This



More Health & Medicine News

Wednesday, October 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Newsy (Sep. 30, 2014) The CDC says a new case of Ebola has not been reported in Nigeria for more than 21 days, leading to hopes the outbreak might be nearing its end. Video provided by Newsy
Powered by NewsLook.com
UN Ebola Mission Head: Immediate Action Is Crucial

UN Ebola Mission Head: Immediate Action Is Crucial

AFP (Sep. 30, 2014) The newly appointed head of the United Nations Mission for Ebola Emergency Response (UNMEER), Anthony Banbury, outlines operations to tackle the virus. Duration: 00:39 Video provided by AFP
Powered by NewsLook.com
CDC Confirms First Case of Ebola in US

CDC Confirms First Case of Ebola in US

AP (Sep. 30, 2014) The CDC has confirmed the first diagnosed case of Ebola in the United States. The patient is being treated at a Dallas hospital after traveling earlier this month from Liberia. (Sept. 30) Video provided by AP
Powered by NewsLook.com
New Breast Cancer Drug Extends Lives In Clinical Trial

New Breast Cancer Drug Extends Lives In Clinical Trial

Newsy (Sep. 30, 2014) In a clinical trial, breast cancer patients lived an average of 15 months longer when they received new drug Perjeta along with Herceptin. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins